Answers are grounded in this paper and cite their sources.
Generally considered indolent, ovarian tumors of low malignant potential (LMP) have a small but finite risk of aggressive behavior. There is controversy surrounding the management of both the indolent and aggressive variants of ovarian LMP tumors. This review will explore the recent advances in the understanding of the genetic composition, pathologic differences and controversies in clinical management of this unique group of ovarian tumors.
No takes yet. Share an insight, caveat, or question.
Winter et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: